|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 12.00 | ACUITE B | Downgraded | Issuer not co-operating* | - |
| Total Outstanding | 12.00 | - | - |
| Total Withdrawn | 0.00 | - | - |
| * The issuer did not co-operate; based on best available information. | |||
|
Rating Rationale |
|
Acuité has downgraded the long-term rating to ‘ACUITE B’ (read as ACUITE B) from 'ACUITE B+' (read as ACUITE B plus) on the Rs. 12.00 crore bank facilities of Impulse Pharma Private Limited(IPPL) on account of information risk. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
| About the Company |
|
The Maharashtra-based Impulse Pharma Private Limited (IPPL) was incorporated in 2002 by Dr. D. J Zawar. The company is engaged in manufacturing and market pharmaceutical formulations in the form of tablets and capsules since 2007. |
| Unsupported Rating |
|
Not Applicable |
| Non-cooperation by the issuer/borrower: |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
| Limitation regarding information availability |
| Rating Sensitivity |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Liquidity Position |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Outlook |
|
Not Applicable |
| Other Factors affecting Rating |
|
None |
| Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
| Operating Income | Rs. Cr. | 88.75 | 79.28 |
| PAT | Rs. Cr. | 8.33 | 7.35 |
| PAT Margin | (%) | 9.39 | 9.26 |
| Total Debt/Tangible Net Worth | Times | 0.23 | 0.21 |
| PBDIT/Interest | Times | 13.51 | 14.43 |
| Status of non-cooperation with previous CRA |
|
Not Applicable |
| Any other information |
|
None |
| Applicable Criteria |
|
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on complexity levels of the rated instrument |
|
||||||||||||||||||||||||||||||||||||
| |
|
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
| * The issuer did not co-operate; based on best available information. | ||||||||||||||||||||||||||||||||||||
|
Contacts |
About Acuité Ratings & Research |
| © Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |
